Versant Vantage I, L.P. Insider Profile
4 Followers
Versant Vantage I, L.P., Ten Percent Owner at Aprea Therapeutics, holds 231.21K shares in Repare Therapeutics (Ticker: RPTX), holds 216.67K shares in Aprea Therapeutics (Ticker: APRE).
Versant Vantage I, L.P.'s Trading History
| RPTXRepare Therapeutics | Jun 07, 2022 | ― | Uninformative Sell | ― | $612.71K | |
| APREAprea Therapeutics | May 20, 2020 | Ten Percent Owner | Uninformative Sell | ― | $87.97K |
You May Also Like
Versant Vantage I, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Versant Vantage I, L.P.?
The percentage of profitable transactions made by Versant Vantage I, L.P. is 100%.
What is the average return per transaction made by Versant Vantage I, L.P.?
The average return per transaction made by Versant Vantage I, L.P. is 22.20%.
What stocks does Versant Vantage I, L.P. hold?
Versant Vantage I, L.P. holds: APRE, RPTX stocks.
What was Versant Vantage I, L.P.'s most profitable transaction?
Versant Vantage I, L.P.’s most profitable transaction was an Informative Buy of APRE stock on October 7, 2019. The return on the trade was 45.10%.
What is Versant Vantage I, L.P.'s role in Aprea Therapeutics?
Versant Vantage I, L.P.'s role in Aprea Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
